Inventor · disambiguated record
Roderick S. Davis
Also filed as: DAVIS RODERICK G · DAVIS RODERICK S
5 granted patents·13 pending applications·53 citations·filing 1996–2023
77Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD8BUSCH-PETERSEN JAKOB3GLAXO GROUP LTD2RHONE POULENC RORER PHARMA2AVENTIS PHARMA INC1
Top patents by PatentIndex Score
18 records- 0182US10604509B2Nrf2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Mar 31, 2020·2 cites·26 claims
- 0280US6034093ASubstituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compoundsRHONE POULENC RORER PHARMA·Filed 1998·Granted Mar 7, 2000·28 cites·30 claims
- 0374US5731315ASubstituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compoundsRHONE POULENC RORER PHARMA·Filed 1996·Granted Mar 24, 1998·20 cites·44 claims
- 0469US2023047296A1Nrf2 REGULATORSGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Application pending·0 cites
- 0567US7612075B2Substituted oxoazaheterocyclyl compoundsAVENTIS PHARMA INC·Filed 2003·Granted Nov 3, 2009·3 cites·15 claims
- 0660US2025368647A1Nitrogen containing condensed 2,3-dihydroquinazolinone compounds as nav1.8 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2023·Application pending·0 cites
- 0758US2020079759A1Nrf2 REGULATORSGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Application pending·0 cites
- 0854US11117905B2Bisaryl heterocycles as NRF2 activatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Sep 14, 2021·0 cites·10 claims
- 0950US2019002454A1NRF2 RegulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 1044US2005131209A1Crystallized hnf4 gamma ligand binding domain polypeptide and screening methods employing sameFiled 2002·Application pending·0 cites
- 1144US2023103791A12,3-dihydroquinazolin compounds as nav1.8 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Application pending·0 cites
- 1242US2008275079A1M3 Muscarinic Acetylcholine Receptor AntagonistsGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 1340US2022002272A1Bisaryl lactams as nrf2 activatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 1438US2007185090A1Muscarinic acetylchoine receptor antagonistsBUSCH-PETERSEN JAKOB·Filed 2004·Application pending·0 cites
- 1535US2013023541A1Voltage-gated sodium channel blockersGLAXO GROUP LTD·Filed 2011·Application pending·0 cites
- 1635US2008234315A1M3 Muscarinic Acetylcholine Receptor AntagonistsBUSCH-PETERSEN JAKOB·Filed 2006·Application pending·0 cites
- 1735US2007293531A1Muscarinic Acetycholine Receptor AntagonistsBUSCH-PETERSEN JAKOB·Filed 2005·Application pending·0 cites
- 1831US2014121213A1Voltage-gated sodium channel blockersBOEHM JEFFREY CHARLES·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roderick S. Davis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →